Evidence map›Paper›PMID 26365552›Full record

ArticleeLife2015

Overflow in science and its implications for trust.

Sabina Siebert, Laura M Machesky, Robert H Insall

Abstract read
In one paragraph

Article in eLife, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Improving the peer review of narrative literature reviews.Research integrity and peer review · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sabina SiebertAdam Smith Business School, University of Glasgow, Glasgow, United Kingdom.
Laura M MacheskyCRUK Beatson Institute for Cancer Research, University of Glasgow, Glasgow, United Kingdom.
Robert H InsallCRUK Beatson Institute for Cancer Research, University of Glasgow, Glasgow, United Kingdom.

Funding

Cancer Research UK 15672Cancer Research UK 15673
6 · The paper itself

Abstract

To explore increasing concerns about scientific misconduct and data irreproducibility in some areas of science, we interviewed a number of senior biomedical researchers. These interviews revealed a perceived decline in trust in the scientific enterprise, in large part because the quantity of new data exceeds the field's ability to process it appropriately. This phenomenon-which is termed 'overflow' in social science-has important implications for the integrity of modern biomedical science.

Indexed as

Reproducibility of ResultsScientific MisconductBiomedical ResearchHumansInterviews as TopicResearch Personneloverflowpoint of viewreproducibilityscientific conducttrust in science

Identifiers

PMID26365552
PMCPMC4563216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.